Moak-Massengill Clinic is categorized under Internal Medicine Doctors in Brookhaven, MS and active since 1981.
Moak-Massengill Clinic was established in 1981, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Antha Restivo, Office Manager at the company’s single location by writing to 1040 D A Biglane Drive, Brookhaven, Mississippi MS 39601 or by phoning (601) 833-5051. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Moak-Massengill Clinic |
Contact Person: | Antha Restivo, Office Manager |
Address: | 1040 D A Biglane Drive, Brookhaven, Mississippi 39601 |
Phone Number: | (601) 833-5051 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1981 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Moak-Massengill Clinic was started in 1981 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Antha Restivo, Office Manager for inquiries that concern Moak-Massengill Clinic by calling the company number (601) 833-5051, as your correspondence is most welcome. Additionally, the physical location of the single location of Moak-Massengill Clinic can be found at the coordinates 31.58966,-90.45862 as well as the street address 1040 D A Biglane Drive in Brookhaven, Mississippi 39601.
For its online presence, you may visit Moak-Massengill Clinic’s website at and engage with its social media outlets through on Twitter and on Facebook.